Humana Inc. (HUM) Downgraded to Market Perform by Raymond James

Market Context

Humana Inc. operates in the Healthcare sector. The stock currently trades at $370.07 with a market capitalization of $32.0B. The stock has gained 66.0% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Raymond James's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Humana Inc.

Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 30, 2026	Guggenheim	Buy	N/A
Jul 30, 2026	Evercore ISI Group	Outperform	N/A
Jul 30, 2026	Raymond James	Market Perform	N/A
Jul 14, 2026	TD Cowen	Hold	N/A
Jul 14, 2026	Truist Securities	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View HUM Stock Page